{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:18:23Z","timestamp":1793654303226,"version":"4.5.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00198-025-07703-x","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:01:43Z","timestamp":1759143703000},"page":"2531-2539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Personalizing denosumab therapy in postmenopausal Indian women with osteoporosis: predictive role of bone turnover markers and body mass index in determining dosing interval"],"prefix":"10.1007","volume":"36","author":[{"given":"Vivek","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-8778","authenticated-orcid":false,"given":"Sanjay K.","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimesh","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhaker D.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"7703_CR1","unstructured":"Foundation IO. The Asian Audit 2021: Epidemiology, costs and burden of osteoporosis in Asia. Nyon: IOF; 2021 2021."},{"key":"7703_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2024.105519","volume":"126","author":"LA Harvey","year":"2024","unstructured":"Harvey LA, Payne NL, Tan A, Zhang J, Lai YC, Taylor ME et al (2024) Variation in mortality following hip fracture across the Asia Pacific region: systematic review and proportional meta-analysis. Arch Gerontol Geriatr 126","journal-title":"Arch Gerontol Geriatr"},{"issue":"8","key":"7703_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756\u2013765","journal-title":"N Engl J Med"},{"key":"7703_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00024","volume":"6","author":"A Zengin","year":"2015","unstructured":"Zengin A, Prentice A, Ward KA (2015) Ethnic differences in bone health. Front Endocrinol (Lausanne) 6","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"7703_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s001980170083","volume":"12","author":"MA Marquez","year":"2001","unstructured":"Marquez MA, Melton LJ 3rd, Muhs JM, Crowson CS, Tosomeen A, O\u2019Connor MK et al (2001) Bone density in an immigrant population from Southeast Asia. Osteoporos Int 12(7):595\u2013604","journal-title":"Osteoporos Int"},{"issue":"11","key":"7703_CR6","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00198-009-0954-6","volume":"20","author":"A Mithal","year":"2009","unstructured":"Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA et al (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807\u20131820","journal-title":"Osteoporos Int"},{"issue":"1","key":"7703_CR7","first-page":"29","volume":"41","author":"SC Thambiah","year":"2020","unstructured":"Thambiah SC, Yeap SS (2020) Osteoporosis in South-East Asian countries. Clin Biochem Rev 41(1):29\u201340","journal-title":"Clin Biochem Rev"},{"issue":"7","key":"7703_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00198-006-0318-4","volume":"18","author":"P Desai Meena","year":"2007","unstructured":"Desai Meena P, Khatkhatay MI, Bhanu Prakash KV, Savardekar LS, Shah RS, Ansari Z (2007) Hormonal profiles and biochemical indices of bone turnover in Indian women. Osteoporos Int 18(7):923\u2013929","journal-title":"Osteoporos Int"},{"key":"7703_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117182","volume":"187","author":"JK Lee","year":"2024","unstructured":"Lee JK, Khor HM, Chotiyarnwong P, Unnanuntana A, Amphansap T, Li-Yu J et al (2024) Bone turnover markers reference database in five Southeast Asian countries. Bone 187","journal-title":"Bone"},{"issue":"1","key":"7703_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.11005\/jbm.2020.27.1.43","volume":"27","author":"DH Cho","year":"2020","unstructured":"Cho DH, Chung JO, Chung MY, Cho JR, Chung DJ (2020) Reference intervals for bone turnover markers in Korean healthy women. J Bone Metab 27(1):43\u201352","journal-title":"J Bone Metab"},{"issue":"1","key":"7703_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0378-5122(96)01042-0","volume":"25","author":"M Iki","year":"1996","unstructured":"Iki M, Kajita E, Dohi Y, Nishino H, Kusaka Y, Tsuchida C et al (1996) Age, menopause, bone turnover markers and lumbar bone loss in healthy Japanese women. Maturitas 25(1):59\u201367","journal-title":"Maturitas"},{"issue":"8","key":"7703_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103841","volume":"9","author":"M Li","year":"2014","unstructured":"Li M, Li Y, Deng W, Zhang Z, Deng Z, Hu Y et al (2014) Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender. PLoS ONE 9(8)","journal-title":"PLoS ONE"},{"key":"7703_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cca.2019.08.012","volume":"498","author":"Y Nishizawa","year":"2019","unstructured":"Nishizawa Y, Miura M, Ichimura S, Inaba M, Imanishi Y, Shiraki M et al (2019) Executive summary of the Japan Osteoporosis Society guide for the use of bone turnover markers in the diagnosis and treatment of osteoporosis (2018 edition). Clin Chim Acta 498:101\u2013107","journal-title":"Clin Chim Acta"},{"issue":"1","key":"7703_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jocd.2019.03.004","volume":"24","author":"CH Wu","year":"2021","unstructured":"Wu CH, Chang YF, Chen CH, Lewiecki EM, W\u00fcster C, Reid I et al (2021) Consensus statement on the use of bone turnover markers for short-term monitoring of osteoporosis treatment in the Asia-Pacific region. J Clin Densitom 24(1):3\u201313","journal-title":"J Clin Densitom"},{"issue":"2","key":"7703_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruy\u00e8re O, Foldes AJ, Garnero P, Griesmacher A et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22(2):391\u2013420","journal-title":"Osteoporos Int"},{"issue":"11","key":"7703_CR16","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1001\/jamainternmed.2015.4799","volume":"175","author":"SL Greenspan","year":"2015","unstructured":"Greenspan SL, Perera S, Resnick NM (2015) Dosing strategies of bone-targeting agents-reply. JAMA Intern Med 175(11):1865\u20131866","journal-title":"JAMA Intern Med"},{"issue":"2","key":"7703_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jbmr.3337","volume":"33","author":"SR Cummings","year":"2018","unstructured":"Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JB, McClung M et al (2018) Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res 33(2):190\u2013198","journal-title":"J Bone Miner Res"},{"key":"7703_CR18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa756","author":"E Tsourdi","year":"2020","unstructured":"Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD (2020) Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa756","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7703_CR19","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab 104(5):1595\u20131622","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"7703_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.7326\/M20-0882","volume":"173","author":"H Lyu","year":"2020","unstructured":"Lyu H, Yoshida K, Zhao SS, Wei J, Zeng C, Tedeschi SK et al (2020) Delayed denosumab injections and fracture risk among patients with osteoporosis\u202f: a population-based cohort study. Ann Intern Med 173(7):516\u2013526","journal-title":"Ann Intern Med"},{"issue":"6","key":"7703_CR21","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3803\/EnM.2024.2047","volume":"39","author":"KM Kim","year":"2024","unstructured":"Kim KM, Jang SA, Hong NK, Kim CS, Rhee Y, Park SW et al (2024) Association of delayed denosumab dosing with increased risk of fractures: a population-based retrospective study. Endocrinol Metab 39(6):946\u2013955","journal-title":"Endocrinol Metab"},{"issue":"6","key":"7703_CR22","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1210\/jc.2007-2814","volume":"93","author":"HG Bone","year":"2008","unstructured":"Bone HG, Bolognese MA, Yuen CK, Kendler DL, Wang H, Liu Y et al (2008) Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. J Clin Endocrinol Metab 93(6):2149\u20132157","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7703_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa2407031","volume":"392","author":"MJ Bolland","year":"2025","unstructured":"Bolland MJ, Nisa Z, Mellar A, Gasteiger C, Pinel V, Mihov B et al (2025) Fracture prevention with infrequent zoledronate in women 50 to 60 years of age. N Engl J Med 392(3):239\u2013248","journal-title":"N Engl J Med"},{"issue":"2","key":"7703_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12020-016-0900-2","volume":"52","author":"SD Vasikaran","year":"2016","unstructured":"Vasikaran SD, Chubb SA (2016) The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis. Endocrine 52(2):222\u2013225","journal-title":"Endocrine"},{"issue":"3","key":"7703_CR25","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jbmr.251","volume":"26","author":"R Eastell","year":"2011","unstructured":"Eastell R, Christiansen C, Grauer A, Kutilek S, Libanati C, McClung MR et al (2011) Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J Bone Miner Res 26(3):530\u2013537","journal-title":"J Bone Miner Res"},{"issue":"1","key":"7703_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jama.2016.19425","volume":"317","author":"AL Himelstein","year":"2017","unstructured":"Himelstein AL, Foster JC, Khatcheressian JL, Roberts JD, Seisler DK, Novotny PJ et al (2017) Effect of longer-interval vs standard dosing of zoledronic acid on skeletal events in patients with bone metastases: a randomized clinical trial. JAMA 317(1):48\u201358","journal-title":"JAMA"},{"issue":"12","key":"7703_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2165\/11594240-000000000-00000","volume":"50","author":"L Sutjandra","year":"2011","unstructured":"Sutjandra L, Rodriguez RD, Doshi S, Ma M, Peterson MC, Jang GR et al (2011) Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosis. Clin Pharmacokinet 50(12):793\u2013807","journal-title":"Clin Pharmacokinet"},{"key":"7703_CR28","unstructured":"Xgeva\u00ae (denosumab) injection, prescribing information. FDA ed. Revised, editor. Silver Spring, MD: U.S. Food and Drug Administration; 2010."},{"issue":"1","key":"7703_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.afos.2024.02.001","volume":"10","author":"T-W Tai","year":"2024","unstructured":"Tai T-W, Chen H-Y, Shih C-A, Huang C-F, McCloskey E, Lee J-K et al (2024) Asia-Pacific consensus on long-term and sequential therapy for osteoporosis. Osteoporos Sarcopenia 10(1):3\u201310","journal-title":"Osteoporos Sarcopenia"},{"key":"7703_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001674","volume":"94","author":"H-F Gu","year":"2015","unstructured":"Gu H-F, Gu L-J, Wu Y, Zhao X-H, Zhang Q, Xu Z-R et al (2015) Efficacy and safety of denosumab in postmenopausal women with osteoporosis. Medicine 94","journal-title":"Medicine"},{"issue":"1","key":"7703_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0889-8529(18)30336-0","volume":"19","author":"PD Delmas","year":"1990","unstructured":"Delmas PD (1990) Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 19(1):1\u201318","journal-title":"Endocrinol Metab Clin North Am"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07703-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07703-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07703-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:31:10Z","timestamp":1764682270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07703-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7703"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07703-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institute\u2019s ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed written consent was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}